Document is current
Any future updates will be listed below
-
Authors
Stoop, T. F.
Seelen, L. W. F.
van ’t Land, F. R.
van der Hout, A. C.
Scheepens, J. C. M.
Ali, M.
Stiggelbout, A. M.
van der Kolk, B. M.
Bonsing, B. A.
Lips, D. J.
de Groot, D. J. A.
van Veldhuisen, E.
Kerver, E. D.
Manusama, E. R.
Daams, F.
Kazemier, G.
Cirkel, G. A.
van Tienhoven, G.
Patijn, G. A.
Lelieveld-Rier, H. N.
de Hingh, I. H.
van Hellemond, I. E. G.
Wijsman, J. H.
Erdmann, J. I.
Mieog, J. S. D.
de Vos-Geelen, J.
de Groot, J. W. B.
Lutchman, K. R. D.
Mekenkamp, L. J.
Kranenburg, L. W.
Beuk, L. P. M.
Nijkamp, M. W.
den Dulk, M.
Polée, M. B.
Homs, M. Y. V.
Wumkes, M. L.
Stommel, M. W. J.
Busch, O. R.
de Wilde, R. F.
Theijse, R. T.
Luelmo, S. A. C.
Festen, S.
Bollen, T. L.
Neumann, U. P.
de Meijer, V. E.
Draaisma, W. A.
Groot Koerkamp, B.
Molenaar, I. Q.
Wolfgang, C. L.
Del Chiaro, M.
Katz, M. G. H.
Hackert, T.
Rietjens, J. A. C.
Wilmink, J. W.
van Santvoort, H. C.
van Eijck, C. H. J.
Besselink, M. G.
,
Bruynzeel, A.
Vlijm, A.
van Asseldonk, A.
Zonderhuis, B.
Javed, A.A.
Sterk, A.
Schoorlemmer, A.
Stam, A.
Nio, C.Y.
van Alphen, E.
van Laarhoven, H.W.M.
van Veenendaal, H.
Griffioen, I.
Rompen, I.F.
Klaase, J.M.
Los, M.
Marting, M.F.M.A.
Liem, M.S.L.
Peters, J.
Peters, L.J.
Garms, Linda
Walma, M.
Brada, L.H.J.
Seijbel, M.
Hildebrand, N.D.
Michiels, N.
Bax, R.
van Dam, R.M.
Achten, S.
Bouwense, S.
Augustinus, S.
Rötgerink, S.
van Ravens, T.W.
Nieuwenhuijs, V.B.
te Riele, W.W.
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (#2021-2 / 14106, #2021-2 / 14106, #2021-2 / 14106, #2021-2 / 14106, #2021-2 / 14106)
Deltaplan Alvleesklierkanker/Maag-Lever-Darm Stichting (#2022-003 / WOO 21-02, #2022-003 / WOO 21-02, #2022-003 / WOO 21-02, #2022-003 / WOO 21-02, #2022-003 / WOO 21-02)
- License Information
-
More Information
Article History
Received: 24 December 2024
Accepted: 17 January 2025
First Online: 19 February 2025
Declarations
:
: The Medical Ethical Committee from the Amsterdam UMC (location Academic Medical Center) has assessed the study protocol (excluding the section about shared decision-making training and the qualitative interview study) and concluded that the Medical Research Involving Human Subjects Act (WMO) does NOT apply to the PREOPANC-4 program (W21_487 # 21.541). The local Medical Ethical Committee from each participating centre has approved their participation.
: The manuscript contains no individual person’s data in any form. Consent is not applicable.
: (1) T.F. Stoop is granted by the Cultuurfonds (Jan de Ruijsscher / Pia Huisman Fonds).(2) M. Del Chiaro has been awarded with an industry grant (Haemonetics, Inc) to conduct a multicentre study to evaluate the prognostic implications of TEG in pancreatic cancer.(3) M. Del Chiaro is co-principal investigator of a Boston Scientific sponsored international multicentre study on the use of intraoperative pancreatoscopy of patients with IPMN.(4) M.G. Besselink has received grants from Ethicon, Medtronic, Intuitive Surgical, Oncosil and is a proctor for Intuitive Surgical.(5) J.W. Wilmink has received grants from MSD, Nordic and Servier and reports an advisory role for MSD, Astra Zeneca and Servier.
